CALUMET SPECIALTY PRODUCTS PARTNERS, L.P. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.42 USD | -1.41% |
|
+0.61% | -13.46% |
| May. 10 | Sector Update: Energy Stocks Decline in Friday Afternoon Trading | MT |
| May. 10 | Transcript : Calumet Specialty Products Partners, L.P., Q1 2024 Earnings Call, May 10, 2024 |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.85 for the current period. Therefore, the company is undervalued.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's earnings growth outlook lacks momentum and is a weakness.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company does not generate enough profits, which is an alarming weak point.
- The company is in debt and has limited leeway for investment
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Oil & Gas Refining and Marketing
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -13.46% | 1.26B | C | ||
| +10.89% | 21.59B | C+ | ||
| +36.29% | 11.64B | B+ | ||
| +3.01% | 10.93B | B | ||
| +34.72% | 9.24B | B+ | ||
| +57.26% | 4.46B | C | ||
| +3.54% | 3.39B | B | ||
| +17.09% | 3.17B | B+ | ||
| -0.81% | 3B | D+ | ||
| +15.38% | 2.87B | B- |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- CLMT Stock
- Ratings Calumet Specialty Products Partners, L.P.
